Endpoint definition
↥| Name | DRUGADVERS_APLAST_ANAEM |
|---|---|
| Long name | Drug-induced aplastic anaemia |
| Hospital Discharge registry | ICD-10: D611 |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| Name | DRUGADVERS_APLAST_ANAEM |
|---|---|
| Long name | Drug-induced aplastic anaemia |
| Hospital Discharge registry | ICD-10: D611 |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 20 | 12 | 8 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 59.21 | 58.11 | 60.85 |
| Case fatality at 5-years (%) | 40.00 | 41.67 | 37.50 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 15.00 | 25.00 | - |
before Drug-induced aplastic anaemia
after Drug-induced aplastic anaemia
Loading survival analyses plot…
Loading survival analyses table…